Abstract
The E7 oncogene is an essential tool used by papillomaviruses to interfere with the cell cycle and cellular differentiation. We investigated the effects of E7 expression on both cellular functions in skeletal muscle cells, a terminally differentiating system. When expressed in myoblasts, E7 impaired differentiation only partially, but allowed continuation of DNA synthesis during and after differentiation. Surprisingly, E7 expression in terminally differentiated myotubes could not reactivate DNA synthesis even though the oncogene bound the retinoblastoma protein, reduced its levels, and increased E2F transcriptional activity. Despite the high cyclin E protein levels induced by E7, the myotubes remained devoid of cyclin E-associated kinase activity. Enforcement of such activity in the presence of E7 brought myotubes into S phase. These results show that E7, unlike other DNA tumor-virus oncogenes, cannot reactivate the cell cycle in postmitotic myotubes. In contrast, E7 allows significant differentiation to occur in the presence of persisting DNA synthesis. These observations distinguish E7 from other functionally related oncogenes and bear significance for the understanding of the natural life cycle of human papillomaviruses. The fact that E7 alone inhibits the initiation but not the maintenance of the postmitotic state indicates that the mechanisms underlying these two functions are at least partially distinct.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Alema' S and Tato' F . (1994). Sem. Cancer Biol., 5, 147–156.
Antinore MJ, Birrer MJ, Patel D, Nader L and McCance DJ . (1996). EMBO J., 15, 1950–1960.
Berezutskaya E, Yu B, Morozov A, Raychaudhuri P and Bagchi S . (1997). Cell Growth Differ., 8, 1277–1286.
Bignami M, Rosa S, La Rocca SA, Falcone G and Tato’ F . (1988). Oncogene, 2, 509–514.
Blau HM, Pavlath GK, Hardeman EC, Chiu C-P, Silberstein L, Webster SG, Miller SC and Webster C . (1985). Science, 230, 758–766.
Boyer SN, Wazer DE and Band V . (1996). Cancer Res., 56, 4620–4624.
Brehm A, Miska EA, McCance DJ, Reid JL, Bannister AJ and Kouzarides T . (1998). Nature, 391, 597–601.
Cardoso MC, Leonhardt H and Nadal-Ginard B . (1993). Cell, 74, 979–992.
Chien WM, Noya F, Benedict-Hamilton HM, Broker TR and Chow LT . (2002). J. Virol., 76, 2964–2972.
Crescenzi M, Soddu S and Tato’ F . (1995). J. Cell. Physiol., 162, 26–35.
Endo T and Nadal-Ginard B . (1989). Cellular and Molecular Biology of Muscle Development: UCLA Symposia on Molecular and Cellular Biology. Kedes LH, Stockdale FE (eds). Alan R Liss, Inc.: New York, pp. 95–104.
Fogel M and Defendi V . (1967). Proc. Natl. Acad. Sci. USA, 58, 967–973.
Gonzalez SL, Stremlau M, He X, Basile JR and Munger K . (2001). J. Virol., 75, 7583–7591.
Haley KP, Overhauser J, Babiss LE, Ginsberg HS and Jones NC . (1984). Proc. Natl. Acad. Sci. USA, 81, 5734–5738.
He TC, Zhou S, da Costa LT, Yu J, Kinzler KW and Vogelstein B . (1998). Proc. Natl. Acad. Sci. USA, 95, 2509–2514.
Hwang SG, Lee D, Kim J, Seo T and Choe J . (2002). J. Biol. Chem., 277, 2923–2930.
Jian Y, Schmidt-Grimminger DC, Chien WM, Wu X, Broker TR and Chow LT . (1998). Oncogene, 17, 2027–2038.
Jones LD, Alani RM and Münger K . (1997). Genes Dev., 11, 2101–2111.
Kyo S, Klumpp DJ, Inoue M, Kanaya T and Laimins LA . (1997). J. Gen. Virol., 78, 401–411.
Latella L, Sacco A, Pajalunga D, Tiainen M, Macera D, D’Angelo M, Felici A, Sacchi A and Crescenzi M . (2001). Mol. Cell. Biol., 21, 5631–5643.
Leone G, DeGregori J, Jakoi L, Cook JG and Nevins JR . (1999). Proc. Natl. Acad. Sci. USA, 96, 6626–6631.
Lipinski MM and Jacks T . (1999). Oncogene, 18, 7873–7882.
Lochmuller H, Johns T and Shoubridge EA . (1999). Exp. Cell Res., 248, 186–193.
Maione R, Fimia GM and Amati P . (1992). Oncogene, 7, 85–93.
Martin LG, Demers GW and Galloway DA . (1998). J. Virol., 72, 975–985.
McMurray HR, Nguyen D, Westbrook TF and McAnce DJ . (2001). Int. J. Exp. Pathol., 82, 15–33.
Muller C, Alunni-Fabbroni M, Kowenz-Leutz E, Mo X, Tommasino M and Leutz A . (1999). Proc. Natl. Acad. Sci. USA, 96, 7276–7281.
Munger K, Basile JR, Duensing S, Eichten A, Gonzalez SL, Grace M and Zacny VL . (2001). Oncogene, 20, 7888–7898.
Nguyen DX, Westbrook TF and McCance DJ . (2002). J. Virol., 76, 619–632.
Ohtsubo M, Theodoras AM, Schumacher J, Roberts JM and Pagano M . (1995). Mol. Cell Biol., 15, 2612–2624.
Pagano M, Pepperkok R, Verde F, Ansorge W and Draetta G . (1992). EMBO J., 11, 961–971.
Pajalunga D, Tognozzi D, Tiainen M, D’Angelo M, Ferrantelli F, Helin K, Sacchi A and Crescenzi M . (1999). Oncogene, 18, 5054–5062.
Porrello A, Cerone MA, Coen S, Gurtner A, Fontemaggi G, Cimino L, Piaggio G, Sacchi A and Soddu S . (2000). J. Cell. Biol., 151, 1295–1304.
Puri PL, Cimino L, Fulco M, Zimmerman C, La Thangue NB, Giordano A, Graessmann A and Levrero M . (1998). Cancer Res., 58, 1325–1331.
Schneider JW, Gu W, Zhu L, Mahdavi V and Nadal-Ginard B . (1994). Science, 264, 1467–1471.
Tedesco D, Baron L, Fischer-Fantuzzi L and Vesco C . (1997). J. Virol., 71, 2217–2224.
Tiainen M, Pajalunga D, Ferrantelli F, Soddu S, Salvatori G, Sacchi A and Crescenzi M . (1996a). Cell Growth Differ., 7, 1039–1050.
Tiainen M, Spitkovsky D, Jansen-Durr P, Sacchi A and Crescenzi M . (1996b). Mol. Cell. Biol., 16, 5302–5312.
Webster KA, Muscat GE and Kedes L (1988). Nature, 332, 553–557.
Yaffe D and Gershon D . (1967). Nature, 215, 421–424.
Zacksenhaus E, Jiang Z, Chung D, Marth JD, Phillips RA and Gallie BL . (1996). Genes Dev., 10, 3051–3064.
Zerfass K, Schulze A, Spitkovsky D, Friedman V, Henglein B and Jansen-Dürr P . (1995). J. Virol., 69, 6389–6399.
Zerfass-Thome K, Schuize A, Zwerschke W, Vogt B, Helin K, Bartek J, Henglein B and Jansen-Durr P . (1997). Mol. Cell Biol., 17, 407–415.
Acknowledgements
We thank S Soddu for reagents and critically reading the manuscript. This work has been supported by Telethon – Italy Grant No. GP 0293/01, an AIRC grant to MC Grant No. ICS 120.4/RA00-90 from the Italian Ministry of Health, and a grant from ASI to MC.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sacco, A., Siepi, F. & Crescenzi, M. HPV E7 expression in skeletal muscle cells distinguishes initiation of the postmitotic state from its maintenance. Oncogene 22, 4027–4034 (2003). https://doi.org/10.1038/sj.onc.1206353
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1206353